Toggle navigation
Home
Search
Services
Blog
Contact
About
Novel Recombinant Serpin for the Treatment of Stroke
Sands, Howard
Sparta Pharmaceutical Corporation, Horsham, PA, United States
Search 7 grants from Howard Sands
Search grants from Sparta Pharmaceutical Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Epigenomics and Transciptomics Core
Adaptive Difficulty Training and Evaluation of Long-Term Skill Learning in a BCI
System of Care Project for Children
Induction of NK-cell ligands by viruses
Perioperative Changes in Acth and Cortisol Response To
Recently added grants:
Dissecting principles of transcription factor binding
The molecular mechanism of LCD, a prevalent and conserved non-apoptotic cell death program
Structural and kinetic investigation of the guanine nucleotide exchange factor Ric-8A and its interaction with G proteins (G?q/G?i)
Architecture and Dynamics of a Gene Regulatory Network Controlling Cell Fate
Deciphering the Sequence Code for Compositional Control of Phase Separated Biomolecular Condensates
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
9R44NS036100-02A1
Application #
2431317
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (11))
Program Officer
Jacobs, Tom P
Project Start
1995-08-15
Project End
1999-08-31
Budget Start
1997-09-01
Budget End
1998-08-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Institution
Name
Sparta Pharmaceutical Corporation
Department
Type
DUNS #
City
Horsham
State
PA
Country
United States
Zip Code
19044
Related projects
NIH 1998
R44 NS
Novel Recombinant Serpin for the Treatment of Stroke
Sands, Howard / Sparta Pharmaceutical Corporation
NIH 1997
R44 NS
Novel Recombinant Serpin for the Treatment of Stroke
Sands, Howard / Sparta Pharmaceutical Corporation
Comments
Be the first to comment on Howard Sands's grant